Chances are, someone in your life is managing a chronic health condition. Maybe it’s a parent with diabetes, a friend navigating obesity, or a partner trying to get ahead of cardiovascular disease. The advice they’ve received from their doctor is almost always the same: eat better, live healthier. What they might not know is that there’s a clinician specifically trained to help them do exactly that—and that their insurance probably covers it.
That disconnect sits at the heart of one of America’s most underappreciated healthcare crises. Six in 10 American adults have at least one chronic cardiometabolic condition. Diabetes, obesity, and cardiovascular disease collectively drive over a trillion dollars in annual healthcare costs. And yet the most effective, evidence-backed intervention for most of these conditions isn’t a new drug or a surgical procedure; it’s a conversation with a registered dietitian.
Nutrition counseling has been covered by insurance for over a decade, but fewer than 1% of Americans who could benefit ever actually access it. The reasons were structural: Supply was fragmented across thousands of small private practices, billing was opaque, and most patients were unaware the benefit even existed. For years, one of healthcare’s most powerful preventative tools sat largely unused.
The emergence of GLP-1 prescriptions has created an enormous new patient population with genuine clinical need for nutritional support. Payers are beginning to connect the dots, as medication alone isn’t sufficient for durable outcomes, and major insurers are moving toward requiring dietitian engagement as a condition of GLP-1 approval. Layered on top is a broader shift away from reactive treatment and toward upstream, preventative cardiometabolic management. At Menlo, we’ve seen structural shifts like this before: The nutrition market today looks a lot like behavioral health did several years ago, when Grow Therapy was born out of a COVID-driven surge in demand. The opening it creates for scalable new infrastructure is just as significant.
Building the Infrastructure Nutrition Care Never Had
Co-founders Aidan, Stephanie, and Sam built Nourish not just from a whiteboard, but from lived experiences. Each had not only faced health challenges that dietitian-led care ultimately helped resolve, but also experienced firsthand how needlessly difficult the care was to access. The three friends and former classmates set out to build the experience they wished existed, and from the moment we met them, their command of the problem, attention to detail, and relentless focus on execution made it clear they were the team to solve it. Today, we couldn’t be more thrilled to announce that Menlo Ventures is leading Nourish’s $100M Series C.
Nourish built the platform that makes nutrition care actually accessible. They connect patients with registered dietitians for insurance-covered virtual sessions, handling credentialing, insurance verification, claims, scheduling, and clinical documentation so dietitians can spend their time on care instead of paperwork. For patients, that means finding a matched provider and booking in minutes, with little to no out-of-pocket cost.
Today, Nourish has a network of more than 10,000 registered dietitians across all 50 states, serving hundreds of thousands of patients. What drives the remarkable advocacy on both sides is how deeply AI is woven into the experience: Session notes write themselves, clinical insights surface automatically from patient data, and prior authorization workflows happen in the background. The result is a platform that gets smarter with every session, and a care experience that feels meaningfully different from anything that came before it.

What makes this particularly powerful is that Nourish has also cracked the problem of patient acquisition. Over the last two years, the team has built a pharma-style field sales motion where dedicated reps cultivate relationships with physicians, converting them into recurring referral sources. With tens of thousands actively referring providers, Nourish has become the clinical-grade platform on which the industry is increasingly standardizing.
And this is just the beginning. By expanding into GLP-1 prescribing, labs, and chronic care management, Nourish is evolving from a nutrition platform into a true longitudinal care partner, built around the whole patient rather than a single touchpoint in their health journey.

Backing the Healthcare Trinity: Building the Future of Care Delivery
This investment deepens a thesis we’ve been building for years around personalized, accessible, insurance-covered care that hits on the “healthcare trinity” we need to see: increased access, better outcomes, lower cost. Grow Therapy offers immediate and reimbursable access to behavioral therapy. Function Health is putting comprehensive diagnostics in the hands of everyday people. Solace is giving patients an advocate to guide them through one of the most confusing systems in their lives. Cartwheel brings mental health care to kids and teens where they already are. And Ophelia makes evidence-based addiction treatment accessible to all.
Nourish is the next chapter in that story—extending the same logic to cardiometabolic health. We believe this category is at a genuine inflection point, and Nourish is best-positioned to define what care here could look like for the next decade and beyond. We couldn’t be more proud to partner with Aidan, Stephanie, Sam, and the rest of the team as they embark on this journey.
If you’re a patient looking for a dietitian, or a provider interested in joining the network, visit nourish.com.
Jean-Paul (JP) Sanday is a partner at Menlo Ventures who invests at the inflection stage. Focused on vertical SaaS and, more broadly, enterprise software, JP is particularly excited about companies defining the future of work, infusing our lives with intelligent automation and democratizing data analytics. His favorite part of the…
Greg is a partner at Menlo Ventures, where he invests in teams trying to solve major problems in life science and healthcare, with a special interest in novel therapeutic platforms, digital health, and transformative technologies. Since joining in 2017, Greg has led Menlo investments including Cartwheel, Clear Labs, Curie, Delfi,…
As a principal at Menlo Ventures, Derek focuses on early-stage investments across AI, cloud infrastructure, and digital health. He partners with companies from seed through inflection, including Anthropic, Eve, Neon, and Unstructured. Derek joined Menlo from Bain & Company, where he advised technology investors on opportunities ranging from machine learning…
Sabrina is an investor at Menlo Ventures, where she focuses on inflection-stage companies in enterprise SaaS, AI/ML, and cloud infrastructure. She’s excited about partnering with founders who challenge the status quo and supporting them in transforming bold visions into enduring businesses. Her passion for startups began at Fastcase (now vLex),…





